4/2
Perelman School of Medicine
An unsolved mystery: Why are we sleepy when sick?
David Raizen, a professor of neurology, alongside PURM student Hina Sako, spent the summer moving forward research examining how sickness affects sleep.
The brain-blood barrier’s role in governing ant behavior
New research from Penn Medicine uncovers a link between a single enzyme and complex social behaviors in ants.
Removing the barrier surrounding solid tumors clears path for T cells
Penn researchers uncover a new way to target solid tumors. Using CAR T cells to remove cancer-associated fibroblasts surrounding pancreatic tumors allows T cells to infiltrate and attack the tumor cells.
Penn Medicine’s Carl June to receive 2024 Breakthrough Prize in Life Sciences
The Richard W. Vague Professor in Immunotherapy in the Perelman School of Medicine is honored for pioneering the development of CAR T cell therapy, which programs patients’ own immune cells to fight their cancer.
Can the COVID playbook help end malaria?
In a Perry World House conversation, Matthew Laurens, Martina Mchenga, and Drew Weissman discussed how lessons from a global pandemic could help in the fight to eradicate malaria.
Genetic switch turns tumor suppressor into oncogene in colorectal cancer
Researchers from the School of Veterinary Medicine have shown that an enzyme that suppresses early-stage colorectal cancer switches to become an oncogene as the cancer progresses.
A link between memory and appetite in the brain to explain obesity
Penn Medicine researchers have found the hippocampal subnetwork, located within the memory center of the brain, is more dysregulated in patients with higher body mass indexes, leading to an inability to control or regulate eating habits.
An immunotherapy strategy against all blood cancers
Researchers at Penn Medicine have demonstrated a new potential treatment using CAR T cell therapy using a CRISPR base-editing to develop a method called “epitope editing.”
A summer studying the aesthetic brain
For third-year Olivia Kim, a PURM research experience with Penn neuroscientist Anjan Chatterjee allowed her to combine her love of neuroscience and art in a working lab.
Trading decisions are observable in the eyes of buyers and sellers
In a new collaborative study, PIK Professor Michael Platt models how the decision-making process unfolds in the brains of buyers and sellers considering a deal. These decisions were observable in eye movements and pupil dilation.
In the News
Scholars at risk in their own countries find a new home at Penn
Penn Global’s Scholars-at-Risk program is featured. Global’s Ezekiel J. Emanuel and Scott Moore, Penn Carey Law’s Eric Feldman, and Wharton’s Jesús Fernández-Villaverde, along with former and current scholars Angel Alvarado, Pavel Golubev, and Jawad Moradi are interviewed.
FULL STORY →
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
FULL STORY →
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Alzheimer’s may be caused by a build-up of fat in brain cells
A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.
FULL STORY →
Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors
A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.
FULL STORY →